Intra-procedural dual phase cone beam computed tomography has a better diagnostic accuracy over pre-procedural MRI and MDCT in detection and characterization of HCC in cirrhotic patients undergoing TACE procedure

被引:11
作者
Lucatelli, Pierleone [1 ]
De Rubeis, Gianluca [1 ]
Corradini, Luca Ginnani [1 ]
Basilico, Fabrizio [1 ]
Di Martino, Michele [1 ]
Lai, Quirino [2 ]
Corradini, Stefano Ginanni [3 ]
Cannavale, Alessandro [1 ]
Nardis, Pier Giorgio [1 ]
Corona, Mario [1 ]
Saba, Luca [4 ]
Catalano, Carlo [1 ]
Bezzi, Mario [1 ]
机构
[1] Sapienza Univ Rome, Dept Diagnost Radiol Oncol & Anatomopathol Sci, Vasc & Intervent Radiol Unit, Viale Policlin 155, I-00161 Rome, RM, Italy
[2] Sapienza Univ Rome, Dept Gen Surg & Organ Transplantat, Viale Policlin 155, I-00161 Rome, RM, Italy
[3] Sapienza Univ Rome, Dept Translat & Precis Med, Viale Policlin 155, I-00161 Rome, RM, Italy
[4] Azienda Osped Univ AOU Cagliari Polo Monserrato, Dept Med Imaging, Via Osped 54, I-09124 Cagliari, CA, Italy
关键词
Hepatocellular cancer; Therapeutic chemoembolization; Cone-Beam computed tomography; Computerized tomography; X ray; Magnetic resonance imaging; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; TRANSARTERIAL CHEMOEMBOLIZATION; HEPATOCELLULAR-CARCINOMA; MULTIDETECTOR CT; LIVER-TUMORS; EMBOLIZATION; PERFORMANCE; GUIDELINES; QUALITY;
D O I
10.1016/j.ejrad.2019.108806
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: This study was directed to compare diagnostic accuracy of dual-phase cone beam computed tomography (DP-CBCT) vs pre-procedural second line imaging modality (SLIM [multidetector computed tomography and magnetic resonance imaging]) to detect and characterize hepatocellular carcinoma (HCC) in cirrhotic patients with indication for trans-arterial chemoembolization (TACE). Methods: This is a single centre, retrospective, and observational study. Exclusion criteria were not-assisted DP-CBCT TACE, and unavailable follow-up SLIM. We evaluated 280 consecutive patients (January/2015-Febraury/2019). Seventy-two patients were eligible. Three radiologists in consensus reviewed: pre-procedural SLIM, DP-CBCT, and SLIM at follow-up, with 4 months of interval between each reading. Hyper-vascular foci (HVF) were detected and characterized. Diameter was recorded. Radiological behaviour, according to LI-RADS criteria, of HFV throughout follow-up time was the reference standard. Diagnostic accuracy was calculated for pre-procedural SLIM and DP-CBCT and evaluated through receiver operating characteristic curve. HVF only visible on DP-CBCT (defined as occult) were analysed. Tumour diameters were compared. Results: Median time between pre-procedural SLIM and DP-CBCT and between DP-CBCT and definitive radiological diagnosis of HVF were 46.0 days (95%CI 36.5-55.0) and 30.5 days (95%CI 29.0-33.0), respectively. DP-CBCT had a better diagnostic performance than pre-examination SLIM (sensitivity 99%vs78%; specificity 89%vs85%; PPV 99%vs99%; NPV 92%vs30%; and accuracy 94%vs79%). DP-CBCT diagnosed 63 occult HVF. Occult HCC were 54/243 (22.2%). Six were occult angiomas. Three were false positive. Mean diameter was significantly higher in DP-CBCT vs pre-procedural SLIM (+ 7.5% [95%CI 3.7-11.3], p < 0.05). Conclusions: DP-CBCT has a better diagnostic accuracy and NPV than pre-procedural SLIM in cirrhotic patients with indication for TACE.
引用
收藏
页数:8
相关论文
共 35 条
  • [1] Growth rate of early-stage hepatocellular carcinoma in patients with chronic liver disease
    An, Chansik
    Choi, Youn Ah
    Choi, Dongil
    Paik, Yong Han
    Ahn, Sang Hoon
    Kim, Myeong-Jin
    Paik, Seung Woon
    Han, Kwang-Hyub
    Park, Mi-Suk
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (03) : 279 - 286
  • [2] Cone Beam Computed Tomography (CBCT) in the Field of Interventional Oncology of the Liver
    Bapst, Blanche
    Lagadec, Matthieu
    Breguet, Romain
    Vilgrain, Valerie
    Ronot, Maxime
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 39 (01) : 8 - 20
  • [3] Quality-Improvement Guidelines for Hepatic Transarterial Chemoembolization
    Basile, Antonio
    Carrafiello, Gianpaolo
    Ierardi, Anna Maria
    Tsetis, Dimitrios
    Brountzos, Elias
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2012, 35 (04) : 765 - 774
  • [4] Optimal Imaging Surveillance Schedules after Liver-Directed Therapy for Hepatocellular Carcinoma
    Boas, F. Edward
    Do, Bao
    Louie, John D.
    Kothary, Nishita
    Hwang, Gloria L.
    Kuo, William T.
    Hovsepian, David M.
    Kantrowitz, Mark
    Sze, Daniel Y.
    [J]. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2015, 26 (01) : 69 - 73
  • [5] Management of Hepatocellular Carcinoma: An Update
    Bruix, Jordi
    Sherman, Morris
    [J]. HEPATOLOGY, 2011, 53 (03) : 1020 - 1022
  • [6] Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Imaging of Hepatocellular Carcinoma in At-Risk Patients
    Chernyak, Victoria
    Fowler, Kathryn J.
    Kamaya, Aya
    Kielar, Ania Z.
    Elsayes, Khaled M.
    Bashir, Mustafa R.
    Kono, Yuko
    Do, Richard K.
    Mitchell, Donald G.
    Singal, Amit G.
    Tang, An
    Sirlin, Claude B.
    [J]. RADIOLOGY, 2018, 289 (03) : 816 - 830
  • [7] CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I. Development, Growth, and Spread: Key Pathologic and Imaging Aspects
    Choi, Jin-Young
    Lee, Jeong-Min
    Sirlin, Claude B.
    [J]. RADIOLOGY, 2014, 272 (03) : 634 - 653
  • [8] Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma A Systematic Review and Meta-analysis
    Chou, Roger
    Cuevas, Carlos
    Fu, Rongwei
    Devine, Beth
    Wasson, Ngoc
    Ginsburg, Alexander
    Zakher, Bernadette
    Pappas, Miranda
    Graham, Elaine
    Sullivan, Sean D.
    [J]. ANNALS OF INTERNAL MEDICINE, 2015, 162 (10) : 697 - +
  • [9] Peritoneal and pleural fluids may appear hyperintense on hepatobiliary phase using hepatobiliary MR contrast agents
    Ciolina, Maria
    Di Martino, Michele
    Bruno, Onorina
    Pommier, Romain
    Vilgrain, Valerie
    Ronot, Maxime
    [J]. EUROPEAN RADIOLOGY, 2018, 28 (07) : 3020 - 3031
  • [10] STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
    Cohen, Jeremie F.
    Korevaar, Daniel A.
    Altman, Douglas G.
    Bruns, David E.
    Gatsonis, Constantine A.
    Hooft, Lotty
    Irwig, Les
    Levine, Deborah
    Reitsma, Johannes B.
    de Vet, Henrica C. W.
    Bossuyt, Patrick M. M.
    [J]. BMJ OPEN, 2016, 6 (11):